OneMedNet Corp ONMD
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 2021-05-07
Chart by TradingView
5/9
Piotroski F — financial health
-197.32
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Revenue | $1.4M | $643,000 | $1.0M | $1.2M |
| Gross profit | -$503,000 | -$281,000 | -$129,000 | -$360,690 |
| Operating income | -$9.7M | -$9.6M | -$6.9M | -$11.4M |
| Net income | -$2.8M | -$10.1M | -$33.8M | -$6.2M |
| Operating cash flow | -$7.5M | -$7.0M | -$4.8M | $87.2M |
| Free cash flow | -$7.5M | -$7.0M | -$4.8M | $87.2M |
| Total assets | $2.2M | $3.7M | $464,000 | $30.4M |
| Total liabilities | $5.1M | $19.7M | $13.9M | $21.2M |
| Shareholders' equity | -$3.0M | -$15.9M | -$13.4M | -$26.4M |
| Ratios | ||||
| Gross margin | -37.0% | -43.7% | -12.6% | -31.3% |
| Operating margin | -711.3% | -1493.8% | -671.2% | -991.2% |
| Net margin | -206.1% | -1575.3% | -3308.5% | -540.4% |
| FCF margin | -553.1% | -1089.1% | -473.6% | 7563.0% |
| Return on assets | -130.2% | -271.8% | -7280.2% | -20.5% |
| Return on equity | 94.5% | 63.5% | 251.3% | 23.6% |
| Debt / equity | -0.07× | -0.15× | -0.03× | — |
| Current ratio | 0.43 | 0.19 | 0.03 | 2.58 |
| Revenue growth | 111.4% | -37.0% | -11.4% | — |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -197.32 (distress)
- Working capital / assets -1.269
- Retained earnings / assets -48.522
- EBIT / assets -4.494
- Equity / liabilities -0.58
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001849380 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.